- Upregulation of Rab11FIP4 has been reported in Hepatocellular carcinoma tissues and cell lines
- Expression of Rab11FIP4 correlates with a worse/poor prognosis and resistance to chemotherapy
- Rab11FIP4 can be involved in the proliferation, migration, invasion, and metastasis of HCC tumor cells.
- A recent study shows that Rab11‐FIP4 enhances resistance to sorafenib therapy.
Was this post helpful?
Let us know if you liked the post. That’s the only way we can improve.
